MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors.
Saved in:
| Title: | MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors. |
|---|---|
| Authors: | Kotch C; Children's Hospital of Philadelphia, Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania (C.K., M.J.F.)., de Blank P; Department of Pediatrics, University of Cincinnati and Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio (P.d.B.)., Fangusaro J; Aflac Cancer Center, Children's Healthcare of Atlanta and Emory University School of Medicine, Atlanta, Georgia (J.F.)., Fisher MJ; Children's Hospital of Philadelphia, Philadelphia and University of Pennsylvania, Philadelphia, Pennsylvania (C.K., M.J.F.). |
| Source: | Neuro-oncology advances [Neurooncol Adv] 2026 Apr 28; Vol. 8 (Suppl 2), pp. ii14-ii24. Date of Electronic Publication: 2026 Apr 28 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101755003 Publication Model: eCollection Cited Medium: Internet ISSN: 2632-2498 (Electronic) Linking ISSN: 26322498 NLM ISO Abbreviation: Neurooncol Adv Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
